US / INGR
Ingredion IncINGR · NYSE
Seen as a commodity processor whose sales swing with raw material pass-through, so investors see no distinct growth story.
Why the market may be pricing it low
Sales rise or fall as raw material costs pass through to prices, so the market treats it as commodity-linked, not a growth business.
net sales decreased 3 percent to $7.2 billion from 2024, which was primarily due to unfavorable price mix, including the pass through of lower corn costs, and lower volumes.MD&A
Repeated plant closures and impairments in Canada, the UK, and Brazil reinforce the view that this is a mature industry still restructuring.
impairment charges for the cessation of operations at our manufacturing facilities in Vanscoy, Canada; Goole, United Kingdom; and Alcantara, BrazilMD&A
Selling starches and sweeteners across 60-plus industries, the company is treated as an undifferentiated commodity ingredient maker.
We develop, produce and sell a variety of food and beverage ingredients, primarily starches and sweeteners, for a broad range of customers in over 60 industries worldwide.Business
What could close the gap
A May 2026 exit/impairment 8-K filing (Item 2.05/2.06) could mark the end of restructuring if closures are now complete.
2026-05-05 Item 2.05,2.068-K filings
Results from the May 2026 shareholder meeting (Item 5.07) could become a turning point for capital allocation policy.
2026-05-21 Item 5.078-K filings
Adjusted ROIC has risen to 15.5%, well above the 10% target, and wider recognition of this could shift perception.
Our long-term objective is to maintain an Adjusted ROIC in excess of 10.0 percent. For 2025, we achieved an Adjusted ROIC of 15.5 percentRisk factors
How a buyer could still lose (value trap)
The only unmet Piotroski criterion is asset turnover improvement, hinting capital efficiency gains may be stalling despite strong earnings.
Based on the figures below
Restructuring and impairment charges from plant closures recur yearly, so underlying profitability may be weaker than adjusted figures suggest.
In 2025, we recorded $13 million of pre-tax restructuring charges primarily related to accelerated depreciation and decommissioning costs for previously announced plant closures and restructuring activities that occurred during the year.Risk factors
Drafted by AI on 29 Sep 2026 from the figures on this page and excerpts of the filing only (no web search). Each point's quote was checked by machine against the filing text; points whose quote could not be found are not shown. These are hypotheses, not findings. Latest 10-K (SEC)
Financial quality (Piotroski F-score)
- ✓Profitable (ROA > 0)
- ✓Positive operating cash flow
- ✓ROA up on last year
- ✓Cash flow exceeds net profit
- ✓Leverage down on last year
- ✓Current ratio up on last year
- ✓No new shares issued
- ✓Gross margin up on last year
- ✗Asset turnover up on last year
Scored out of the checks with data, scaled to 9. Compares the latest year with the year before.
Figures
- Sales
- $7.2bn
- Operating profit
- $860m
- Net profit
- $592m
- Operating cash flow
- $805m
- Cash
- $948m
- Debt
- $1.8bn
- Equity
- $4.5bn
Latest twelve months to 2026-06-30; F-score for the fiscal year to 2025-12-31
This site ranks companies whose share price is low relative to their profits, using public filings and market prices, and has AI draft hypotheses on why they are cheap from those filings. The hypotheses are unverified. Nothing here is a price forecast or a recommendation to buy or sell. Not investment advice.
Updated 29 Sep 2026 12:31 JST